首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到17条相似文献,搜索用时 250 毫秒
1.
探索肿瘤生长性别差异的原因。研究雌激素及其拮抗剂他莫昔芬对可移植性小鼠肉瘤180生长的影响;采用同位素方法,证实了完整小鼠腹腔巨噬细胞对^3H-雌二醇的特异性细胞内结合。肯定了小鼠腹腔巨噬细胞是一种雌激素受体阳性细胞。雌性小鼠肿瘤生长速率比雄性小鼠低是因为雌性激素激活了雌激素受体阳性的巨噬细胞的缘故。  相似文献   

2.
【目的】克隆弓背青鳉(Oryzias curvinotus)雌激素受体基因(Estrogen receptor, er),分析在组织、胚胎发育时期中表达特征和雌二醇暴露后表达响应,为探究er介导雌激素调控机制提供理论依据。【方法】通过弓背青鳉肝脏转录组数据筛选进行er序列扩增,实时定量PCR(RT-q PCR)检测不同组织、不同胚胎发育时期和雌二醇暴露后的er表达量。【结果】3种ocuerα/erβ1/erβ2的编码区序列分别为1 860 bp、1 689 bp和2 007 bp,编码氨基酸个数相应为619、562和688。定量结果显示,3种er主要在肝脏和性腺高表达。胚胎发育过程中,ocuerα在卵裂期至囊胚期表达量低,在囊胚期后表达量逐渐上升持续到孵化;2种ocuerβ亚型均在胚胎发育初期有较高表达,随后ocuerβ1在原肠胚后开始降低,ocuerβ2在囊胚期后开始降低,在器官发育后期表达量均逐渐上升直至孵化。弓背青鳉仔鱼雌二醇暴露结果显示,各浓度雌二醇暴露均能使ocuerα和弓背青鳉卵黄蛋白基因(Vitellogenin,vtg)表达量上升,ocuerβ1仅在20μg/L上调,ocuerβ2表达量下调。【结论】ocuer不同亚型在介导雌激素调控中起着重要作用。  相似文献   

3.
根据已知罗氏沼虾(Macrobrachium rosenbergii)雌激素相关受体基因序列(Gen Bank登录号KU899089),设计含有酶切位点的特异性引物,PCR扩增得1 374 bp的开放阅读框序列,构建原核表达载体p ET-32a-ERR,并优化诱导浓度、诱导时间、诱导温度等表达条件。结果表明,ERR蛋白在温度35℃、IPTG浓度0.1 mmol/L条件下,诱导4 h时表达量较佳。  相似文献   

4.
研究了方格星虫多糖对小鼠免疫功能的影响。结果表明:方格星虫粗多糖(CSG)能够对抗环磷酰胺引起的小鼠胸腺萎缩和脾萎缩,明显拮抗白细胞减少,对正常小鼠免疫器官没有明显的增重作用;对正常小鼠腹腔巨噬细胞吞噬中性红能力有显著的增强作用。方格星虫多糖粗品(CSG)和精制多糖(SG1和SG2)能够促进小鼠脾淋巴细胞增殖,且能与ConA协同作用。  相似文献   

5.
以Fat-1转基因小鼠和野生型C57BL/6小鼠为研究对象,经侧脑室注射脂多糖(lipopolysaccharide,LPS)诱导中枢炎症模型,测定抑郁样行为糖水偏好度和悬尾实验、腹腔巨噬细胞活性及其吞噬能力、脑炎症小胶质细胞的标记物CD11b基因与蛋白的表达水平,用以研究Fat-1对LPS诱发的炎症和抑郁样行为的作用。结果表明:在野生型小鼠中,LPS降低小鼠糖水偏好度,延长悬尾静止不动时间,增加腹腔巨噬细胞的活性和吞噬能力,上调CD11b基因和蛋白表达水平;而LPS不能引起Fat-1转基因小鼠出现上述类似变化。侧脑室注射LPS可引起野生型小鼠炎症反应和抑郁样行为,而Fat-1转基因小鼠可通过脑内和体内合成n-3 PUFAs抵抗LPS诱发的上述抑郁样变化。  相似文献   

6.
采用四甲基偶氮唑盐(MTT)微量酶反应比色法检查赤魟三种组织(皮肤、软组织和软骨)粗提物对体外培养的人癌细胞生长的影响,用腹腔注射或灌胃法检查赤魟三种组织粗提物对小鼠移植性肉瘤180(S180)和肝癌(H22)生长的影响。结果表明,赤魟组织粗提物对体外培养的人早幼粒白血病细胞(HL-60)、人子宫颈癌细胞(HeLa)和人低分化鼻咽癌细胞(CNE-2Z)的生长无明显影响,赤魟组织粗提物无论腹腔注射还是灌胃均显著抑制小鼠肉瘤和小鼠肝癌的生长,且对体重无明显影响;当三种组织粗提物以500mg/kg/d(相当生药量,下同)的剂量连续腹腔注射(ip)15d时,对S180的抑制率分别为63.9%、47.2%和80.3%;以3500mg/kg/d连续灌胃(ig)15d时,对S180的抑制率分别为66.9%、61.5%和66.9%;以500mg/kg/d连续腹腔注射15d时,对H22的抑制率分别为43.3%、43.3%和80.4%。  相似文献   

7.
【目的】优化方格星虫(Sipunculus nudus L.)酶解工艺条件,探讨其酶解液对细胞免疫活性的影响。【方法】在确定实验用酶和单因素实验基础上,利用响应面设计建立数学模型,以水解度为响应值,进行3因素3水平的响应面分析,得到最适酶解条件。以小鼠脾淋巴细胞的增殖、小鼠腹腔巨噬细胞生成NO量和吞噬能力来评价酶解液对免疫细胞的促进作用。【结果】以动物水解蛋白酶和风味蛋白酶组合用酶效果最佳,方格星虫酶解的适宜条件为pH 7.0、加酶量5 000 U/g、液料比3∶1,55℃酶解5.2 h,其水解度为38.92%;以此条件得到的酶解液进行实验,酶解液质量浓度为0.9 mol/mL时,小鼠脾淋巴细胞的增殖率为30.57%,小鼠腹腔巨噬细胞生成NO能力为56.2μmol/L,吞噬能力D(540 nm)值均明显高于阳性对照组(P0.01)。【结论】方格星虫酶解液对细胞免疫具有促进作用。  相似文献   

8.
菲律宾蛤仔糖胺聚糖抗肿瘤活性研究   总被引:2,自引:0,他引:2  
从菲律宾蛤仔全脏器中提取得到糖胺聚糖粗品(CRG),通过DEAE-52离子交换柱层析得到纯品(RG),分别采用MTT法和动物移植性肿瘤模型检测其体外和体内抗肿瘤活性,同时测量荷瘤小鼠的胸腺指数的脾指数;建立小鼠免疫抑制模型,并测量正常小鼠和免疫抑制小鼠的胸腺指数、脾指数和碳粒廓清指数。结果显示,菲律宾蛤仔糖胺聚糖可以抑制体外培养的人肝癌Bel7402肿瘤细胞的生长,能显著抑制移植性S180肉瘤的生长,可抑制荷瘤小鼠的脾肿大现象,对环磷酰胺造成的小鼠胸腺和脾脏萎缩有抵抗和修复作用。  相似文献   

9.
利用慢性不可预知轻度应激诱导大鼠抑郁模型,以体质量、糖水偏好和旷场实验作为抑郁样行为评价指标,以腹腔巨噬细胞吞噬能力、皮质酮激素水平为外周免疫和应激激素指标,测定脑内多不饱和脂肪酸(PUFAs)探讨脑内细胞膜组成的变化。结果表明:与对照组相比,应激组大鼠在体质量、糖水偏好及旷场实验中穿越格数和站立次数均有明显下降,而皮质酮激素和腹腔巨噬细胞吞噬能力均显著增加,脑内n-3 PUFAs、n-3/n-6 PUFAs减少,喂饲EPA可显著改善应激引起的变化。  相似文献   

10.
儿茶酚胺类药物对草鱼鱼种生长激素分泌的影响   总被引:2,自引:0,他引:2  
通过腹腔注射药物,尾静脉取血,放射免疫测定激素含量等方法研究了L-多巴等几种药物对草鱼鱼种生长的激素分泌的影响,发现腹腔注射L-多巴,阿朴吗啡可以显著提高草鱼鱼种血清生长激素水平,而腹腔注射多巴胺,去甲肾上腺素,肾上腺素和6-羟多巴则可明显降低草鱼鱼种血清生长激素水平。  相似文献   

11.
In this study, we isolated a polysaccharide from Branchiostoma belcheri (PBB) by enzymatic protein hydrolysis and alcohol precipitation. We investigated the effects of PBB supplementation on DNA oxidation and growth of the transplanted tumor cells Sarcoma (S180) in mice. Sixty healthy Kunming mice weighing between 18 and 25 g were randomly assigned to 6 groups, each consisting of 10 animals. All the mice, except for the blank control group, were inoculated with S180 sarcoma cells into the axilla of the left foreleg. PBB was given to mice by gavage at doses of 0 (model control), 25, 50, or 100 mg/kg b.w. in 0.2 ml saline for 30 days. The fifth group of S180-mice was given cytoxan (50 mg/kg) by peritoneal injection as a positive control group. The animals had free access to food and water. The mice were sacrificed after the final treatment and blood was quickly collected. Spontaneous and oxidized DNA damage of peripheral lymphocytes induced by H2O2 were analyzed by SCGE. O6-methyl-guanine (O6-MeG) was measured by high-performance capillary zone electrophoresis. The average tumor weights (0.856–1.118 g) of the three PBB groups were significantly lower than that of the model control group (1.836 g) (p<0.05). The tumor inhibition ratios of the PBB groups were 39.1%–53.4% and similar to the cytoxan positive group (57.5%). There were no significant differences in spontaneous DNA damage in peripheral lymphocytes among the groups. The oxidative DNA damage induced by 10 μmol/L H2O2 in the 50 and 100 mg/kg b.w. groups were 246.1 AU and 221.7 AU, respectively, both of which were significantly lower than that in the model group (289.0 AU; p<0.05). The plasma concentrations of O6-MeG in the 25, 50, and 100 mg/kg supplemented groups were 2.09 μmol/L, 1.86 μmol/L, and 1.63 μmol/L, respectively, all of which were significantly lower than that of the model group (2.67 μmol/L; p<0.05). These results indicated that PBB may have antioxidative activity and thus reduce oxidation-induced DNA damage.  相似文献   

12.
通过盐析、离子交换、凝胶过滤和疏水层析等分离纯化,同步进行抗血管生成和抗肿瘤生长检测,从赤魟(Dasyatis akajei)组织获得强抗血管生成成分福安肽-03(Fuantai-03,FAT-03)的纯品(纯度>95%);使用Edman降解法测定FAT-03 N-末端氨基酸组成和序列,RACE系统技术解析FAT-03的一级结构。结果表明:FAT-03明显抑制鸡胚绒毛尿囊膜血管生成和BALB/c裸小鼠Lewis肺癌的生长及肝转移,且其效果与剂量相关。FAT-03分子的一级结构即其氨基酸组成和序列已被确定。  相似文献   

13.
赤魟尾刺提取物的抗肿瘤作用   总被引:1,自引:1,他引:0  
<正>赤魟Dasyatis akajei(Muller&henle)隶属于软骨鱼纲,下孔总目,鲼形目,魟科,魟属,常栖息于底质为泥沙的深潭中[1-3]。赤魟肉性味甘、咸平,有补气之功效。用其熬油,主治小儿疳积。尾刺研末入药,对治疗胃癌、食道癌、肺癌、乳腺炎、咽喉炎、疟疾、牙痛、魟鱼尾刺刺伤均有一定疗效[4]。赤魟尾刺含有多种毒素,有重要药理作用。涂洪斌等克隆出编码赤魟肿瘤抑制因子IPL的全长cDNA序列[5],并报道了赤魟亲环素A的融合表达、纯化及活性特征[6]。目前,赤魟尾刺的生物活性成分及其相关毒理和药理作用仍不清楚[7]。笔者研究了赤魟尾刺提取物(extracts of caudal spine,ECS)对小鼠可移植性肿瘤生长的影响,现将结果报告如下。  相似文献   

14.
Hepatitis B virus(HBV) is a significant global pathogen and efficient cure for HBV patients is still a challenging goal. We previously reported that acidic mucopolysaccharide from stichopus japonicus selenka(SJAMP) could inhibit HBs Ag and HBe Ag expression in vitro. However, the potential anti-HBV effects of SJAMP in vivo have not yet been explored. In this study, we show that SJAMP exhibits potent anti-HBV activity in HBV transgenic mice in a dose-dependent manner. Specifically, sixty HBV transgenic male BALB/c mice were randomly selected to receive the treatment of PBS, low dose SJAMP(30 mg kg~(-1)), middle dose SJAMP(40 mg kg~(-1)), high dose SJAMP(50 mg kg~(-1)) and IFN(45 IU kg~(-1)) for 30 d. SJAMP treatment suppressed serum HBV-DNA, and liver HBs Ag and HBc Ag levels in HBV-transgenic mice. The present study highlights the potential application of SJAMP in HBV therapy.  相似文献   

15.
Oyster peptides were produced from Crassostrea hongkongensis and used as a new protein source for the preparation of an oyster peptide-based enteral nutrition formula (OPENF). Reserpine-induced malabsorption mice and cyclophosphamide-induced immunosuppression mice were used in this study. OPENF powder is light yellow green and has a protein-fat-carbohydrate ratio of 16:9:75 with good solubility in water. A pilot study investigating immune functional impacts of the OPENF on mice show that the OPENF enhanced spleen lymphocyte proliferation and the activity of natural killer (NK) cells in BALB/c mice. Furthermore, OPENF can improve intestinal absorption, increase food utilization ratio, and maintain the normal physiological function of mice. These results suggest that oyster peptides could serve as a new protein source for use in enteral nutrition formula, but more importantly, also indicate that OPENF has an immunostimulating effect in mice.  相似文献   

16.
Hepatitis B virus(HBV) is a significant global pathogen and efficient cure for HBV patients is still a challenging goal. We previously reported that acidic mucopolysaccharide from stichopus japonicus selenka(SJAMP) could inhibit HBs Ag and HBe Ag expression in vitro. However, the potential anti-HBV effects of SJAMP in vivo have not yet been explored. In this study, we show that SJAMP exhibits potent anti-HBV activity in HBV transgenic mice in a dose-dependent manner. Specifically, sixty HBV transgenic male BALB/c mice were randomly selected to receive the treatment of PBS, low dose SJAMP(30 mg kg-1), middle dose SJAMP(40 mg kg-1), high dose SJAMP(50 mg kg-1) and IFN(45 IU kg-1) for 30 d. SJAMP treatment suppressed serum HBV-DNA, and liver HBs Ag and HBc Ag levels in HBV-transgenic mice. The present study highlights the potential application of SJAMP in HBV therapy.  相似文献   

17.
To investigate the antitumor effect of bromophenol derivatives in vitro and Leathesia nana extract in vivo, six bromophenol derivatives 6-(2,3-dibromo-4,5-dihydroxybenzyl)-2,3-dibromo-4,5-dihydroxy benzyl methyl ether (1), (+)-3-(2,3-dibromo-4,5-dihydroxyphenyl)-4-bromo-5,6-dihydroxy-1,3-dihydroisobenzofuran (2), 3-bromo-4-(2,3-dibromo-4,5-dihydroxybenzyl)-5-methoxymethyl-pyrocatechol (3),2,2',3,3'-tetrabromo-4,4',5,5'-tetrahydroxy-diphenylmethane (4), bis(2,3-dibromo-4,5-dihydroxybenzyl) ether (5), 2,2',3-tribromo-3',4,4',5-tetrahydroxy-6'-ethyloxymethyldiphenylmethane (6) were isolated from brown alga Leathesia nana, and their cytotoxicity were tested by MTr assays in human cancer cell lines A549, BGC-823, MCF-7, B16-BL6, HT-1080, A2780, Bel7402 and HCT-8. Their inhibitory activity against protein tyrosine kinase (PTK) with over-expression of c-kit was analyzed also by ELISA. The antitumor activity of ethanolic extraction of Leathesia nana (EELN) was evaluated on S180-bearing mice.All compounds showed very potent cytotoxicity against all of the eight cancer cell lines with IC50 below 10 μg/mL. In PTK inhibition study, all bromophenol derivatives showed moderate inhibitory activity and compounds 2, 5 and 6 showed significant bioactivity with the inhibition ratio of 77.5%, 80.1% and 71.4%,respectively. Pharmacological studies reveal that EELN could inhibit the growth of Sarcoma 180 tumor and increase the indices of thymus and spleen to improve the immune system remarkably in vivo. Results indicated that the bromophenoi derivatives and EELN can be used as potent antitumor agents for PTK over-expression of c-kit and considered in a new therapeutic strategy for treatment of cancer.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号